| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |